990 related articles for article (PubMed ID: 29097388)
1. Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
Magvanjav O; Gong Y; McDonough CW; Chapman AB; Turner ST; Gums JG; Bailey KR; Boerwinkle E; Beitelshees AL; Tanaka T; Kubo M; Pepine CJ; Cooper-DeHoff RM; Johnson JA
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097388
[TBL] [Abstract][Full Text] [Related]
2. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG
Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
[TBL] [Abstract][Full Text] [Related]
4. Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses).
McDonough CW; Magvanjav O; Sá ACC; El Rouby NM; Dave C; Deitchman AN; Kawaguchi-Suzuki M; Mei W; Shen Y; Singh RSP; Solayman M; Bailey KR; Boerwinkle E; Chapman AB; Gums JG; Webb A; Scherer SE; Sadee W; Turner ST; Cooper-DeHoff RM; Gong Y; Johnson JA
Circ Genom Precis Med; 2018 Apr; 11(4):e001854. PubMed ID: 29650764
[TBL] [Abstract][Full Text] [Related]
5. Genome-Wide Prioritization and Transcriptomics Reveal Novel Signatures Associated With Thiazide Diuretics Blood Pressure Response.
Shahin MH; Sá AC; Webb A; Gong Y; Langaee T; McDonough CW; Riva A; Beitleshees AL; Chapman AB; Gums JG; Turner ST; Boerwinkle E; Scherer SE; Sadee W; Cooper-DeHoff RM; Johnson JA
Circ Cardiovasc Genet; 2017 Jan; 10(1):. PubMed ID: 28115488
[TBL] [Abstract][Full Text] [Related]
6. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
Bakris GL; Cooper-Dehoff RM; Zhou Q; Kupfer S; Champion A; Pepine CJ;
Am J Cardiovasc Drugs; 2007; 7 Suppl 1():25-9. PubMed ID: 19845074
[TBL] [Abstract][Full Text] [Related]
7. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.
Holzgreve H; Nakov R; Beck K; Janka HU
Am J Hypertens; 2003 May; 16(5 Pt 1):381-6. PubMed ID: 12745200
[TBL] [Abstract][Full Text] [Related]
9. G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
Vandell AG; Lobmeyer MT; Gawronski BE; Langaee TY; Gong Y; Gums JG; Beitelshees AL; Turner ST; Chapman AB; Cooper-DeHoff RM; Bailey KR; Boerwinkle E; Pepine CJ; Liggett SB; Johnson JA
Hypertension; 2012 Oct; 60(4):957-64. PubMed ID: 22949529
[TBL] [Abstract][Full Text] [Related]
10. A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST).
Ried LD; Tueth MJ; Handberg E; Kupfer S; Pepine CJ;
Psychosom Med; 2005; 67(3):398-406. PubMed ID: 15911902
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).
Brunner M; Cooper-DeHoff RM; Gong Y; Karnes JH; Langaee TY; Pepine CJ; Johnson JA;
Am J Cardiol; 2007 Jun; 99(11):1549-54. PubMed ID: 17531579
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to-moderate hypertension. Scandinavian Study Group.
Os I; Hotnes T; Dollerup J; Mogensen CE
Am J Hypertens; 1997 Aug; 10(8):899-904. PubMed ID: 9270085
[TBL] [Abstract][Full Text] [Related]
13. Treating essential hypertension. The first choice is usually a thiazide diuretic.
Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
[TBL] [Abstract][Full Text] [Related]
14. Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).
Cooper-Dehoff R; Cohen JD; Bakris GL; Messerli FH; Erdine S; Hewkin AC; Kupfer S; Pepine CJ;
Am J Cardiol; 2006 Oct; 98(7):890-4. PubMed ID: 16996868
[TBL] [Abstract][Full Text] [Related]
15. The treatment of severe hypertension with trandolapril, verapamil, and hydrochlorothiazide. Trandolapril/Verapamil Multicenter Study Group.
Punzi HA; Novrit BA
J Hum Hypertens; 1997 Aug; 11(8):477-81. PubMed ID: 9322827
[TBL] [Abstract][Full Text] [Related]
16. The fixed combination of verapamil SR/trandolapril.
Widimský J
Expert Opin Pharmacother; 2000 Mar; 1(3):515-35. PubMed ID: 11249535
[TBL] [Abstract][Full Text] [Related]
17. Effect of strict blood pressure control on proteinuria in renal patients treated with different antihypertensive drugs.
García de Vinuesa S; Luño J; Gómez-Campderá F; Ridao N; Sánchez M; Dall'Anese C; Valderrábano F
Nephrol Dial Transplant; 2001; 16 Suppl 1():78-81. PubMed ID: 11369828
[TBL] [Abstract][Full Text] [Related]
18. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
[TBL] [Abstract][Full Text] [Related]
19. INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study.
Cooper-DeHoff RM; Handberg EM; Mancia G; Zhou Q; Champion A; Legler UF; Pepine CJ
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1329-40. PubMed ID: 19900016
[TBL] [Abstract][Full Text] [Related]
20. Genome Wide Association Study Identifies the
Singh S; McDonough CW; Gong Y; Alghamdi WA; Arwood MJ; Bargal SA; Dumeny L; Li WY; Mehanna M; Stockard B; Yang G; de Oliveira FA; Fredette NC; Shahin MH; Bailey KR; Beitelshees AL; Boerwinkle E; Chapman AB; Gums JG; Turner ST; Cooper-DeHoff RM; Johnson JA
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29523524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
